Charles River Laboratories International (CRL) Gross Profit (2009 - 2026)

Charles River Laboratories International has reported Gross Profit for 18 years, with the latest figure at $452.1 million in Q2 2026.

• On a quarterly basis, Gross Profit rose 1.08% year-over-year to $452.1 million in Q2 2026; TTM through Jun 2026 was $1.7 billion, a 9.36% decrease from a year earlier, with the FY2025 full-year figure at $1.7 billion, changed 0.21% from the prior year.
• Gross Profit was $452.1 million for Q2 2026 at Charles River Laboratories International, up from $386.9 million in the prior quarter.
• The five-year high for Gross Profit was $695.0 million in Q4 2023, with the low at $344.8 million in Q1 2024.
• Average Gross Profit over 5 years is $439.4 million, with a median of $420.7 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2025: Gross Profit soared 39.91% in 2023, then slumped 36.89% in 2025.
• Over 5 years, Gross Profit stood at $496.7 million in 2022, then surged by 39.91% to $695.0 million in 2023, then dropped by 5.51% to $656.6 million in 2024, then sank by 36.89% to $414.4 million in 2025, then rose by 9.09% to $452.1 million in 2026.
• The last three Gross Profit figures came in at $452.1 million (Q2 2026), $386.9 million (Q1 2026), and $414.4 million (Q4 2025), per Business Quant data.